Adjusting survival curves for imbalances in prognostic factors. by Gregory, W. M.
The Macmillan Press Ltd., 1988
Adjusting survival curves for imbalances in prognostic factors
W.M. Gregory
Clinical Operational Research Unit, University College London, Gower Street, London WCIE 6BT, UK.
Summary A new method for comparing the survival of two or more groups of patients adjusting for factors
distributed unevenly between the groups is presented. This is a development of previous methods, and
provides a graphical counterpart to Mantel's adjusted chi-square statistic. The method can be used to
retrospectively stratify for prognostic factors, and to provide additional validation and interpretation of
multivariate results, including those based on Cox's proportional hazards model. Like Mantel's adjusted chi-
square statistic, the method adjusts at every event, based on the numbers of patients still at risk in each of the
groups, and is thus able to show up time-dependent effects: factors can be seen to be relevant during certain
periods of the study only. The method presented thus allows curves to be drawn as they would have been
expected to look, had the prognostic factors been evenly distributed between the groups.
Many clinical trials are evaluated primarily on the basis of
differences in survival between groups of patients. This
usually involves computing actuarial curves for the groups
under consideration (Kaplan & Meier, 1958) and using a
significance test such as the log-rank test (Peto et al., 1977)
to evaluate possible differences.
However, there are often factors, measurable on presen-
tation, which may influence the subsequent survival of the
patient, and these factors may not be balanced in the groups
to be compared. In this case, a simple comparison may yield
spurious results, and some form of multivariate analysis is
often required. Two common methods are employed to this
end, viz. to compute adjusted chi-square statistics based on
summations of observed and expected numbers over all the
prognostic sub-groups (Mantel, 1966), or to run a multivar-
iate regression using the proportional hazards model of Cox
(Cox, 1972). The first of these two methods would be greatly
enhanced by some graphical counterpart, while the second
introduces a number of additional assumptions (proportiona-
lity of the hazards, and a linear relationship between the
hazard function and the variable) which can be difficult to
validate (Kay, 1983), and loses the merit of simplicity.
Hankey & Myers (1971) produced a method of adjusting
survival curves as an adjunct to the adjusted chi-square
statistic. However, the method was cumbersome, since it
required dividing the survival period into intervals, each
needing to contain a substantial number of patients, and
adjusting the death rate in each such interval. An alternative
method adjusting at every event (Murthy & Haywood, 1981;
Chang et al., 1982), was devised to avoid this problem. The
method divided the patients into subgroups for each treat-
ment and each prognostic indicator. It then gave a weighting
to each of these groups, such that, for each prognostic
group, the same proportion of patients would be at risk
within each treatment group as compared to the whole
population. This method is an improvement on that of
Hankey & Myers (1971), but fails to take into account
possible time trends in the data, since the initial weightings
are applied over the whole time period. Thus, even though
the proportions of good and bad risk factors in the treat-
ment groups may change as time progresses and deaths
occur, the same weights are applied throughout.
A development of this method is presented, where weights
are derived at every event, based on the numbers at risk in
each subgroup at that time, providing a more accurate
reflection of Mantel's adjusted chi-square statistic, and
allowing for possible time trends in the data. Thus, curves
can be drawn, as they would have been expected to look,
had the prognostic factors been evenly distributed between
the groups.
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Method
The following notation will be used to describe the survival
data. Consider for the moment just two groups. Suppose
there is a total of K deaths, at times tk (k = I,. . ,K), ranked
in ascending time order in the two groups combined. Let Lik
(i = 1,2) be the number of patients at risk of death in each of
the two groups respectively at this time. Let dk = 1 if death is
in group 1, 0 if death is in group 2. This situation is shown
in Table I.
Then
E(dk)=Llk/Tk
Var (dk) = L kL2kT2k
and a 1-degree-of-freedom continuity-corrected chi-square
can be calculated, enabling a comparison of survival in the
two groups, namely
X2= ( Edk-EE(dk) -O. S)2/ Var(dk)
where the sum is over all deaths. This is the rank order
statistic described by Mantel (Mantel, 1966), and further
explored by Peto & Pike (1973), who showed that the
computationally simpler method of deriving overall observed
and expected numbers, and performing a chi-square on these,
approximated to the Mantel statistic when calculated with-
out the continuity correction. Extension of the chi-square
statistic to more than two groups has been discussed (Mantel
& Haenszel, 1959). Extension of the adjusted curves to more
than two groups is relatively straightforward. The unadjusted
(Kaplan-Meier) survival curve for group i (i= 1.I) is
given by
g~~
L Lk-dik ti(t)k=[l "iki/ tk<t ik (1)
Suppose that the treatment groups are not similarly distri-
buted over a set of J prognostic subgroups. Let fj be the
proportion of persons in the jth such group. Then the
adjusted (Kaplan-Meier) survival curve for treatment i
Table I Survival status of patients by group for kth
death
Died Survived Total
Group 1 dk Llk-dk Llk
Group 2 l-dk L2k-l-dk L2k
1 Llk+L2k - Tk
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(i= 1, ...,I), as defined by Chang (Chang et al., 1982), is given
by
v
S*~(t)= f3igi(t)
j- 1
where Sijft) represents the (actuarial) probability that an
individual in prognostic sub-group j (j=1,2,...,J) will sur-
vive to time T>t, as given by (1).
To take into account the changing numbers at risk in each
subgroup throughout the study, and thus allow for possible
time-trends, it is necessary to compute the proportions fJk in
each prognostic subgroup before each event tk. These are
given by
fjk=L.jklL..k (j=1,*--,J, k=1,...,K).
where L.jk represents the number at risk in all treatment
groups combined, for prognostic group j, at time tk, and L .k
extends this summation to include all prognostic groups as
well, at time tk. Let Lijk represents the number at risk in
treatment group i, for prognostic group j, at time tk. Let
dijk=1 if death is in treatment group i and prognostic group
j, 0 otherwise. Then the new adjusted survival curves are
given by
(¶2K =(Ljk
-dijk)
tkS<( t =j= Lijk
0)
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Figure 1 Survival by haemoglobin, adjusted for albumin (above
and below 33gl-1), showing how the survival by haemoglobin
would be expected to look had the albumin values been equally
distributed between the two groups.
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Having derived the adjusted curves in this way, adjusted
hazard plots are a relatively straightforward extension. The
hazard function is defined (Dixon, 1983) over a particular
time interval as the relative risk of dying as compared to
surviving in that interval. The adjusted hazard can be
obtained using the same formula, but multiplying the
numbers at risk, numbers dying, and numbers censored by
the proportions fjk for each time.
Example
An example of the adjustment technique is given in Figure 1.
The data is taken from a trial at St. Bartholomew's Hospital
evaluating CHOP+moderate dose mid-cycle methotrexate in
high grade non-Hodgkin's lymphoma (Dhaliwal et al., 1984).
The survival for those patients with a haemoglobin above
and below 12gI - on presentation is plotted. Presentation
albumin was also a strong predictor of survival in these
patients, and haemoglobin and albumin values were cor-
related. The adjusted curves, represented by the broken lines
in Figure 1, demonstrate that the difference found in survival
between the two haemoglobin levels could not be explained
merely by differences in albumin values between the two
groups. A detailed breakdown of the adjustment process for
the first 10 deaths is given in Table II. The adjustment for
albumin is most marked over the early part of the curve,
especially the first year, as can be clearly seen from the
hazard and adjusted hazard plots (Figures 2 and 3 respecti-
vely). Thereafter the adjustment becomes less pronounced
and subsequent to a year and a half, negligible. Thus the
adjustment method is accounting for time-related effects.
Clinically it would be expected that patients with a low
albumin would be more likely to die early on, but that once
they had survived this initial high risk period, their risk
would return to that of the group as a whole.
A fortran program has been written to perform the
adjustments and draw the curves, Figures 1, 2 and 3 being
examples.
Discussion
In many diseases factors are being identified which prognos-
ticate for differences in survival and relapse-free survival
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Figure 2 Hazard rates by haemoglobin group (above and below
12g -1), showing an increased hazard in patients with lower
haemoglobins (scale shows relative risk of dying as opposed to
surviving per year).
01)
Co0
V
N
Co
I
12
HB > 12
1 2 3 4 5 6
Time (years)
Figure 3 Hazard rates by haemoglobin, adjusted for albumin
(above and below 33gl-1), showing a reduction in the early
difference between the hazards as compared to the unadjusted
plot (Figure 2).
between groups of patients. When several such factors are
identified for a given disease multivariate methods are
needed to evaluate the relevance of these factors, since they
are often correlated and inter-dependent. The most com-
monly used multivariate method in the analysis of survival
data is that described by Cox (Cox, 1972). Though a method
of drawing adjusted curves based on the Cox model has been
derived (Makuch, 1982), the model itself has drawbacks. It
involves a number of assumptions, for instance proportion-
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Table II Example showing derivation of adjusted survival percentages - first 10 deaths only
Numbers at risk (Lijk) and dying (dijk)
Hb<12 Hb> 12
Total / \ / \ Group I Group 2 Unadjusted Adjusted
Time number Alb<33 Alb>33 Alb <33 Alb>33 (Alb (Alb survivals: survivals:
tk at / \ / \ / \ / \ .33) >33) (equation 1) (equation 2)
(days) risk dllk Lllk dl2k L12k d2lk L2Ik d22k L22k flk f2k 31(t) S2(t) STJ4t) S2*t)
1 103 0 18 0 23 1 10 0 52 0.272 0.728 100.0 98.4 100.0 97.3
4 102 1 18 0 23 0 9 0 52 0.265 0.735 97.6 98.4 98.5 97.3
6 101 0 17 2 23 0 9 0 52 0.257 0.743 92.7 98.4 92.2 97.3
9 99 2 17 0 21 1 9 0 52 0.263 0.737 87.8 96.8 89.3 94.4
11 96 0 15 0 21 0 8 1 52 0.240 0.760 87.8 95.2 89.3 93.1
12 95 1 15 0 21 0 8 0 51 0.242 0.758 85.4 95.2 87.9 93.1
18 94 1 14 0 21 0 8 0 51 0.234 0.766 82.9 95.2 86.4 93.1
ality of the hazard functions in the different prognostic
groups and linearity of the factors in their relationship to the
hazard function, which are often difficult to demonstrate
(Kay, 1983). Furthermore, the simplicitv and ease of under-
standing of the results is lessened, with the clinician often
having to take on trust the results presented to him by a
statistician, since the mathematics is beyond him. As a result,
the interaction and feedback between the clinician, who
understands the clinical implications, and the statistician,
who often does not, can be be severely impaired.
Methods of easily portraying the consequences on survival
of inter-relationships between prognostic variables, without
these assumptions, have been derived, but have various
drawbacks. An extension of one of these methods which
avoids these drawbacks and provides a direct counterpart to
Mantel's adjusted chi-square statistic is presented. The
method enables actuarial curves to be adjusted for factors
imbalanced between groups or treatments. It uses the
numbers at risk at each time point in each sub-group, to
derive the expected survival, in the same fashion as the log-
rank test, and the adjusted chi-square statistic of Mantel.
Thus allowance is made for time-related effects in the data.
If an initial imbalance between the treatment groups is no
longer manifest later in the curve, as a result of deaths
altering the proportions of patients left in the different (pre-
treatment) prognostic subgroups, the weightings will return
to unity, as desired, rather than remaining at their initial
values, as in the method presented by Chang (Chang et al.,
1982).
The variances of several different models including the
Cox model, and the adjustment method of Chang have been
compared (Gail & Byar, 1986). The method presented here
will have a similar variance to the Chang method. Generally,
as more parameters are introduced, the variance decreases,
but the likelihood of the model becoming inappropriate
increases. The two approaches can be usefully combined,
since the adjustment method can be used to check the
proportionality of the hazards in the Cox model, by adjust-
ing for other prognostic factors, as in Figure 3. Particular
relationships of interest can be shown graphically, indepen-
dently of the multivariate model assumptions. Interaction
effects can be investigated more closely, and time-dependent
effects can be clearly seen.
The hazard rates for treatment groups, or for groups
defined by a prognostic variable, can be influenced by other
variables in two different ways. There may be a change over
time in the prognostic composition of the groups, or a
prognostic factor may have an effect which varies over time
(e.g. an initially low albumin relating to a high risk early on,
but to no risk at a later time). The latter effect implies
failure of the proportional hazards model. These two effects
may occur together, as in the example provided. It is
however possible to distinguish between the two effects by
comparing, at each time, the prognostic composition of the
different treatment groups with the percentage adjustment at
that time. If there are periods when the composition remains
unequal (e.g. there is a greater proportion of low albumins
in one group than another), but little or no adjustment is
taking place, then a time varying effect would be evident.
In conclusion this method should provide an additional
useful technique for the analysis of survival data, and the
interpretation of the results of multivariate analyses.
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